HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bin Xu Selected Research

Cerebral Revascularization

1/2022Simultaneous Clipping and Superficial Temporal Artery-Middle Cerebral Artery Bypass for Unruptured Middle Cerebral Artery Aneurysm Concomitant with Proximal Stenosis.
11/2019Evaluation of 99mTC-ECD SPECT/CT brain Imaging with NeuroGam analysis in Moyamoya disease after surgical revascularization.
1/2018Treatment of aneurysms in patients with moyamoya disease: a 10-year single-center experience.
11/2014Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
6/2014Haemodynamic analysis of vessel remodelling in STA-MCA bypass for Moyamoya disease and its impact on bypass patency.
10/2012Efficacy of extracranial-intracranial revascularization for non-moyamoya steno-occlusive cerebrovascular disease in a series of 66 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bin Xu Research Topics

Disease

288Neoplasms (Cancer)
11/2022 - 11/2002
66Neoplasm Metastasis (Metastasis)
11/2022 - 11/2002
61Prostatic Neoplasms (Prostate Cancer)
11/2022 - 06/2009
51Infections
08/2022 - 06/2003
41Carcinoma (Carcinomatosis)
01/2022 - 01/2003
32Inflammation (Inflammations)
08/2022 - 01/2013
30Hepatocellular Carcinoma (Hepatoma)
06/2022 - 11/2002
29Breast Neoplasms (Breast Cancer)
06/2022 - 10/2006
27Carcinogenesis
01/2022 - 01/2011
26Obesity
10/2021 - 05/2005
24Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2010
21Wounds and Injuries (Trauma)
08/2022 - 01/2014
21Pain (Aches)
01/2022 - 06/2008
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2014
19Body Weight (Weight, Body)
05/2021 - 01/2010
18Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 11/2009
18Stomach Neoplasms (Stomach Cancer)
01/2022 - 05/2006
18Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 12/2015
17Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 07/2010
16Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2011
13Fibrosis (Cirrhosis)
08/2022 - 04/2002
13Hemorrhage
04/2022 - 03/2003
13COVID-19
10/2021 - 01/2020
13Lung Neoplasms (Lung Cancer)
01/2021 - 11/2012
12Melanoma (Melanoma, Malignant)
06/2022 - 04/2011
12Glioma (Gliomas)
04/2022 - 10/2014
12Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2009
11Mitochondrial Diseases (Mitochondrial Disease)
09/2022 - 01/2014
11Stroke (Strokes)
03/2022 - 11/2015
11Adenocarcinoma of Lung
01/2021 - 11/2011
11Disease Progression
01/2021 - 06/2008
10Insulin Resistance
01/2022 - 07/2009
10Ischemia
05/2021 - 10/2003
10Schizophrenia (Dementia Praecox)
12/2019 - 10/2005
9Hypertension (High Blood Pressure)
08/2022 - 01/2016
9Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 06/2012
9Diabetes Mellitus
02/2021 - 07/2004
9Hyperlipidemias (Hyperlipidemia)
01/2021 - 01/2013
9Adenocarcinoma
01/2021 - 03/2009
8Heart Failure
03/2022 - 12/2014
8Atrial Fibrillation
12/2021 - 09/2011
8Acquired Immunodeficiency Syndrome (AIDS)
11/2021 - 02/2010
8Colonic Neoplasms (Colon Cancer)
02/2021 - 05/2013
8Hypoxia (Hypoxemia)
02/2021 - 10/2008
8Poisoning
11/2020 - 10/2013
8Constipation
08/2020 - 03/2014

Drug/Important Bio-Agent (IBA)

106Proteins (Proteins, Gene)FDA Link
08/2022 - 11/2002
62Biomarkers (Surrogate Marker)IBA
03/2022 - 10/2009
45MicroRNAs (MicroRNA)IBA
05/2022 - 04/2010
43Biological ProductsIBA
04/2022 - 04/2005
38Messenger RNA (mRNA)IBA
06/2022 - 11/2002
31CytokinesIBA
12/2021 - 04/2002
30Therapeutic UsesIBA
11/2022 - 02/2004
25Pharmaceutical PreparationsIBA
03/2022 - 12/2004
25Long Noncoding RNAIBA
03/2022 - 09/2016
24RNA (Ribonucleic Acid)IBA
06/2022 - 10/2005
22AntigensIBA
01/2021 - 06/2009
16VaccinesIBA
08/2022 - 01/2006
15Peptides (Polypeptides)IBA
08/2022 - 01/2014
15Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2009
15AndrogensIBA
01/2020 - 06/2009
14Circular RNAIBA
11/2022 - 01/2019
14CholesterolIBA
03/2022 - 06/2011
14Interleukin-6 (Interleukin 6)IBA
01/2022 - 04/2011
14EnzymesIBA
01/2021 - 07/2010
13Transcription Factors (Transcription Factor)IBA
04/2022 - 04/2011
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2021 - 02/2004
12DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2006
11LipidsIBA
09/2021 - 07/2008
11Indicators and Reagents (Reagents)IBA
01/2021 - 01/2015
11Insulin (Novolin)FDA Link
01/2018 - 06/2004
10Blood Glucose (Blood Sugar)IBA
03/2022 - 07/2009
10ManganeseIBA
02/2022 - 12/2016
10Phosphotransferases (Kinase)IBA
01/2021 - 03/2009
10Triglycerides (Triacylglycerol)IBA
01/2021 - 01/2014
9Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 07/2006
9Lysine (L-Lysine)FDA Link
01/2022 - 04/2011
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 03/2009
9InterleukinsIBA
07/2020 - 04/2003
9Small Interfering RNA (siRNA)IBA
01/2020 - 07/2014
8Competitive Endogenous RNAIBA
01/2022 - 01/2016
8C-Reactive ProteinIBA
12/2021 - 01/2018
8Interleukin-10 (Interleukin 10)IBA
11/2020 - 04/2003
8oxidized low density lipoproteinIBA
05/2020 - 01/2014
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 10/2003
7Immune Checkpoint InhibitorsIBA
06/2022 - 01/2018

Therapy/Procedure

106Therapeutics
06/2022 - 05/2008
37Drug Therapy (Chemotherapy)
01/2022 - 05/2006
20Electroacupuncture
03/2022 - 05/2005
20Immunotherapy
01/2022 - 01/2014
18Aftercare (After-Treatment)
11/2021 - 12/2008
16Length of Stay
01/2022 - 12/2012
16Radiotherapy
01/2022 - 01/2003
15Castration
01/2022 - 08/2012
11Nephrectomy
01/2022 - 01/2015
11Prostatectomy (Retropubic Prostatectomy)
01/2022 - 01/2010
10Hepatectomy
06/2022 - 01/2004
10Lasers (Laser)
01/2022 - 09/2012
8Operative Time
01/2022 - 02/2014
8Acupuncture Points (Acupuncture Point)
11/2021 - 12/2010